Ganciclovir Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-173

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ganciclovir (NDC 42023-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ganciclovir For Injection Usp 1

FDA Label Image

Ganciclovir For Injection Usp 2

FDA Label Image

Ganciclovir For Injection Usp 3

This appears to be a graph titled "ICM 1653: Time to Progression of CMV Retinitis". The x-axis is labeled "Time From Start of Maintenance Therapy (Days)" and the y-axis is labeled "Proportion Without Progression". The graph shows the proportion of individuals without progression of CMV retinitis over time from the start of maintenance therapy, with percentages marked at various points on the x-axis.*

FDA Label Image

Ganciclovir For Injection Usp 4

FDA Label Image

Ganciclovir For Injection Usp 5

FDA Label Image

Ganciclovir For Injection Usp 6

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.